Abstract
Flow-mediated vasodilation (FMV), brachial artery flow (BAF), and brachial artery diameter were evaluated in 30 patients with congestive heart failure before and after cilazapril treatment.
While mean pulmonary artery pressure and pulmonary capillary wedge pressure decreased significantly, flow-mediated vasodilation and left ventricular ejection fraction increased significantly following cilazapril administration (P<0.001). Brachial artery diameter and brachial artery flow did not change following the treatment period (P>0.05).
In conclusion, short term cilazapril administration improved endothelial function and pulmonary pressure in patients with congestive heart failure.
